Iovance Biotherapeutics had a revenue of 67.45M in the quarter ending Sep 30, 2025, with 12.52%. This bring the company's revenue in the last twelve months to 250.43M, Decreased 3.69%. In the fiscal year ending Dec 31, 2024, Iovance Biotherapeutics had annual revenue of 164.07M with 13698.99% growth.